178 related articles for article (PubMed ID: 22873408)
1. BIK (NBK) is a mediator of the sensitivity of Fanconi anaemia group C lymphoblastoid cell lines to interstrand DNA cross-linking agents.
Prieto-Remón I; Sánchez-Carrera D; López-Duarte M; Richard C; Pipaón C
Biochem J; 2012 Nov; 448(1):153-63. PubMed ID: 22873408
[TBL] [Abstract][Full Text] [Related]
2. Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines.
Kruyt FA; Dijkmans LM; van den Berg TK; Joenje H
Blood; 1996 Feb; 87(3):938-48. PubMed ID: 8562965
[TBL] [Abstract][Full Text] [Related]
3. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
4. FANCC, FANCE, and FANCD2 form a ternary complex essential to the integrity of the Fanconi anemia DNA damage response pathway.
Gordon SM; Alon N; Buchwald M
J Biol Chem; 2005 Oct; 280(43):36118-25. PubMed ID: 16127171
[TBL] [Abstract][Full Text] [Related]
5. The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality.
Pang Q; Christianson TA; Keeble W; Diaz J; Faulkner GR; Reifsteck C; Olson S; Bagby GC
Blood; 2001 Sep; 98(5):1392-401. PubMed ID: 11520787
[TBL] [Abstract][Full Text] [Related]
6. ∆Np73 is capable of inducing apoptosis by co-ordinately activating several BH3-only proteins.
Sánchez-Carrera D; García-Puga M; Yáñez L; Romón Í; Pipaón C
Biosci Rep; 2015 Apr; 35(3):. PubMed ID: 26182360
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin triggers apoptotic or nonapoptotic cell death in Fanconi anemia lymphoblasts in a concentration-dependent manner.
Ferrer M; Izeboud T; Ferreira CG; Span SW; Giaccone G; Kruyt FA
Exp Cell Res; 2003 Jun; 286(2):381-95. PubMed ID: 12749865
[TBL] [Abstract][Full Text] [Related]
8. Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex.
Noll M; Battaile KP; Bateman R; Lax TP; Rathbun K; Reifsteck C; Bagby G; Finegold M; Olson S; Grompe M
Exp Hematol; 2002 Jul; 30(7):679-88. PubMed ID: 12135664
[TBL] [Abstract][Full Text] [Related]
9. Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated.
Kennedy RD; Chen CC; Stuckert P; Archila EM; De la Vega MA; Moreau LA; Shimamura A; D'Andrea AD
J Clin Invest; 2007 May; 117(5):1440-9. PubMed ID: 17431503
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of TP53 associated genes in Fanconi anemia cells after mitomycin C and hydroxyurea treatment.
Martinez A; Hinz JM; Gómez L; Molina B; Acuña H; Jones IM; Frias S; Coleman MA
Mutat Res; 2008 Oct; 656(1-2):1-7. PubMed ID: 18647660
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of STAT1 in Fanconi anemia group A lymphoblasts correlate with the cells' sensitivity to DNA interstrand crosslinking drugs.
Prieto-Remón I; Sánchez-Carrera D; López-Duarte M; Richard C; Pipaón C
Haematologica; 2013 May; 98(5):705-13. PubMed ID: 23585528
[TBL] [Abstract][Full Text] [Related]
12. A role for the Fanconi anemia C protein in maintaining the DNA damage-induced G2 checkpoint.
Freie BW; Ciccone SL; Li X; Plett PA; Orschell CM; Srour EF; Hanenberg H; Schindler D; Lee SH; Clapp DW
J Biol Chem; 2004 Dec; 279(49):50986-93. PubMed ID: 15377654
[TBL] [Abstract][Full Text] [Related]
13. DNA cross-linker-induced G2/M arrest in group C Fanconi anemia lymphoblasts reflects normal checkpoint function.
Heinrich MC; Hoatlin ME; Zigler AJ; Silvey KV; Bakke AC; Keeble WW; Zhi Y; Reifsteck CA; Grompe M; Brown MG; Magenis RE; Olson SB; Bagby GC
Blood; 1998 Jan; 91(1):275-87. PubMed ID: 9414295
[TBL] [Abstract][Full Text] [Related]
14. Loss of FANCC function is associated with failure to inhibit late firing replication origins after DNA cross-linking.
Phelps RA; Gingras H; Hockenbery DM
Exp Cell Res; 2007 Jul; 313(11):2283-92. PubMed ID: 17490643
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the Fanconi anemia protein FA-C in repair processes of oxidative DNA damages.
Lackinger D; Ruppitsch W; Ramirez MH; Hirsch-Kauffmann M; Schweiger M
FEBS Lett; 1998 Nov; 440(1-2):103-6. PubMed ID: 9862435
[TBL] [Abstract][Full Text] [Related]
16. Functional defects in the fanconi anemia pathway in pancreatic cancer cells.
van der Heijden MS; Brody JR; Gallmeier E; Cunningham SC; Dezentje DA; Shen D; Hruban RH; Kern SE
Am J Pathol; 2004 Aug; 165(2):651-7. PubMed ID: 15277238
[TBL] [Abstract][Full Text] [Related]
17. The Fanconi anemia core complex forms four complexes of different sizes in different subcellular compartments.
Thomashevski A; High AA; Drozd M; Shabanowitz J; Hunt DF; Grant PA; Kupfer GM
J Biol Chem; 2004 Jun; 279(25):26201-9. PubMed ID: 15082718
[TBL] [Abstract][Full Text] [Related]
18. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG.
de Winter JP; van der Weel L; de Groot J; Stone S; Waisfisz Q; Arwert F; Scheper RJ; Kruyt FA; Hoatlin ME; Joenje H
Hum Mol Genet; 2000 Nov; 9(18):2665-74. PubMed ID: 11063725
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow failure in the Fanconi anemia group C mouse model after DNA damage.
Carreau M; Gan OI; Liu L; Doedens M; McKerlie C; Dick JE; Buchwald M
Blood; 1998 Apr; 91(8):2737-44. PubMed ID: 9531583
[TBL] [Abstract][Full Text] [Related]
20. Fanconi anemia type C-deficient hematopoietic cells are resistant to TRAIL (TNF-related apoptosis-inducing ligand)-induced cleavage of pro-caspase-8.
Platzbecker U; Kurre P; Guardiola P; Ward JL; Radich JP; Kiem HP; Deeg HJ
Exp Hematol; 2004 Sep; 32(9):815-21. PubMed ID: 15345282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
